P590: PRELIMINARY SAFETY AND EFFICACY OF BGB‐11417, A POTENT AND SELECTIVE B‐CELL LYMPHOMA 2 (BCL2) INHIBITOR, IN PATIENTS (PTS) WITH ACUTE MYELOID LEUKEMIA (AML)

Autor:	Shortt, J., Tan, S. Y., Cannell, P., Ng, T. F., Fong, C. Y., Ramanathan, S., Rajagopal, R., Leitch, S., Gasiorowski, R., Grove, C., Lenton, D., Tan, P., DiNardo, C., Ling, M. T., Cheng, S., Liu, Y., Co, M., Chan, W. Y., Simpson, D., Wei, A. H.
Zdroj:	HemaSphere; 2022 Supplement 3, Vol. 6, p489-490, 2p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text